title: Reproductive and Developmental Toxicity of Orally Administered Botanical Composition, UP446-Part I: Effects on Embryo-Fetal Development in New Zealand White Rabbits and Sprague Dawley Rats.
abstract: The pharmacotoxicology impacts of dietary supplements taken at the time of pregnancy have remained alarming since women are the frequent herbal medicine users in many countries as a complement to the conventional pregnancy management. The use of herbal medicines and diet supplements in expectant mothers linked closely to the health of the childbearing mothers and the fetuses where the lack of developmental safety data imposes a challenge to make the right choices. Here, we describe the potential adverse effects of UP446, a standardized bioflavonoid composition from the roots of Scutellaria baicalensis and the heartwoods of Acacia catechu, on embryo-fetal development following maternal exposure during the critical period of major organogenesis in rabbits and rats. Pregnant dams were treated orally with UP446 at doses of 250, 500, and 1000 mg/kg/day during gestation. The number of resorptions, implantations, litter size, body weights, and skeletal development was evaluated. Maternal food intake and body, tissue, and placenta weight were also assessed. There were no statistically significant differences in implantation, congenital malformation, embryo-fetal mortalities, and fetuses sex ratios in all dosing groups of both species. Therefore, the no observed adverse effect level of UP446 was considered to be greater than 1000 mg/kg in both the maternal and fetus in both species.
authors: Unigen Inc, Seattle, Washington.
authors: Mesfin
authors: M
authors: Yimam
authors: Unigen Inc., Dongnam-Gu, Cheonan-Si, Chungnam, Korea.
authors: Young-Chul
authors: YC
authors: Lee
authors: Unigen Inc., Dongnam-Gu, Cheonan-Si, Chungnam, Korea.
authors: Eu-Jin
authors: EJ
authors: Hyun
authors: Unigen Inc, Seattle, Washington.
authors: Qi
authors: Q
authors: Jia
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000473:pathology*; D000284:Administration, Oral; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000633:toxicity; D047108:Embryonic Development / Q000187:drug effects*; D005260:Female; D047109:Fetal Development / Q000187:drug effects*; D008297:Male; D018811:Maternal Exposure / Q000009:adverse effects*; D009929:Organ Size / Q000187:drug effects; D010936:Plant Extracts / Q000008:administration & dosage / Q000633:toxicity*; D011247:Pregnancy; D011817:Rabbits; D051381:Rats; D017207:Rats, Sprague-Dawley; D012098:Reproduction / Q000187:drug effects; D031364:Scutellaria baicalensis
chemical_list: D016861:Cyclooxygenase Inhibitors; D010936:Plant Extracts; C499814:Scutellaria baicalensis extract; C574443:UP446
keywords: Acacia catechu; Scutellaria baicalensis; developmental toxicity; embryo-fetal